← Leaderboards
Hayk Davtyan
University Of California-Irvine
$2,871,844
Attributed
$2,871,844
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $591.3K · FY2018–22$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,871,844 · 1
By mechanism
R01$2,871,844 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California-Irvine
Same institution · by research overlap
- Kim Green$36,308,762
- Mathew Mark Blurton-Jones$14,315,430
- Seyed Ali Mortazavi$28,674,217
- Munjal M Acharya$4,511,622
- Masashi Kitazawa$7,173,826
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCouplingCalciumAffectB-LymphocytesAge RelatedAgonistBeta Amyloid PathologyBindingBiological Response ModifiersClustered Regularly Interspaced Short Palindromic RepeatsBrainBrain CellAmyloid Beta-ProteinAbeta ClearanceCalcium SignalingCell Differentiation ProcessCell LineCell MembraneCellsCell TypeClinical TrialsCodeCsf1 Gene
Grant awards (5)
Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease$546,576
R01 · FY2022 · AG · contact PI
Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease$570,535
R01 · FY2021 · AG · contact PI
Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease$576,849
R01 · FY2020 · AG · contact PI
Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease$586,575
R01 · FY2019 · AG · contact PI
Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease$591,309
R01 · FY2018 · AG · contact PI